SCHEMBL8274381

SCHEMBL8274381

CC(C)(C)c1cccc(C=NO)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HTT P42858 2/20 0.47
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALOX12 P18054 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ACHE P22303 4/20 0.40
POLB P06746 1/20 0.40
PKM P14618 1/20 0.40
MEN1 O00255 1/20 0.39
CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14088919 1.00 MAPT (0.51) MAPTSMN1; SMN2HTTKDM4EALDH1A1
SCHEMBL18767289 0.82 HDAC4 (0.40) MAPTSMN1; SMN2HDAC4HDAC2HDAC8
SCHEMBL2165184 0.81 RECQL (0.55) MAPTSMN1; SMN2HTTKDM4EALDH1A1
SCHEMBL746313 0.81 RECQL (0.55) MAPTSMN1; SMN2HTTKDM4EALDH1A1
SCHEMBL29942690 0.81 HDAC4 (0.39) MAPTSMN1; SMN2HDAC4HDAC2HDAC8
SCHEMBL23752855 0.81 HDAC4 (0.39) MAPTSMN1; SMN2HDAC4HDAC2HDAC8
SCHEMBL746312 0.81 RECQL (0.55) MAPTSMN1; SMN2HTTKDM4EALDH1A1
SCHEMBL23752854 0.81 HDAC4 (0.39) MAPTSMN1; SMN2HDAC4HDAC2HDAC8
Methylamine SCHEMBL9389458 0.80 RECQL (0.55) MAPTSMN1; SMN2HTTKDM4EKMT2A
SCHEMBL11339460 0.79 HTT (0.59) MAPTSMN1; SMN2HTTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4269702-A Ore treatment process IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1981-05-26 US claimed
US-12570675-B2 Boronic acid compounds LG CHEM, LTD. (KR) 2026-03-10 US disclosed
US-20240101579-A1 BORONIC ACID COMPOUNDS LG CHEM, LTD. (KR) 2024-03-28 US disclosed
EP-4242213-A1 BORONIC ACID COMPOUND Lg Chem, Ltd. (KR) 2023-09-13 EP disclosed
CN-116568310-A Boric acid compounds 株式会社LG化学 2023-08-08 CN disclosed
WO-2022123530-A1 BORONIC ACID COMPOUND 주식회사 엘지화학 2022-06-16 WO disclosed
US-20090076088-A1 Thrombin Receptor Antagonists SCHERING CORPORATION 2009-03-19 US disclosed
US-20090069383-A1 Thrombin Receptor Antagonists SCHERING CORPORATION 2009-03-12 US disclosed
US-7488742-B2 Thrombin receptor antagonists SCHERING CORPORATION (US) 2009-02-10 US disclosed
US-20040152736-A1 Thrombin receptor antagonists TOPROL ACQUISITION LLC 2004-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076088-A1 Thrombin Receptor Antagonists CNR1, CNR2, TBXA2R MAPT 2199/4885SMN1; SMN2 4636/4885HTT 3629/4885
US-12570675-B2 Boronic acid compounds PSMB6, PSMB3, PSMB2 MAPT 3120/4885SMN1; SMN2 777/4885HTT 1191/4885
US-20040152736-A1 Thrombin receptor antagonists CNR1, TBXA2R, CNR2 MAPT 2644/4885SMN1; SMN2 4388/4885HTT 3552/4885
US-20090069383-A1 Thrombin Receptor Antagonists CNR1, CNR2, TBXA2R MAPT 2199/4885SMN1; SMN2 4636/4885HTT 3629/4885
US-20240101579-A1 BORONIC ACID COMPOUNDS PSMB11, PSMB1, BACH1 MAPT 685/4885SMN1; SMN2 213/4885HTT 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.